Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joanna J. Song
Observed names:
J Song,
JOANNA J. SONG,
Joanna J Song,
Joanna Song,
Song Joanna
Institution:
Baylor College of Medicine
Observed institutions:
University of Calgary,
Baylor College of Medicine,
University of South Florida,
University of Florida,
Provincial Laboratory of Public Health,
Stanford Medicine,
Stanford University
show all 7
ORCID:
0000-0002-1321-7896
Observed ORCID:
0000-0002-1321-7896
OpenAlex ID:
A5041454366
Multi-species biofilms defined from drinking water microorganisms provide increased protection against chlorine disinfection
2013
·
Monika Schwering
, Joanna Song
, et al.
·
Biofouling
·
175
PDF
Predicting Unplanned 7-day Intensive Care Unit Readmissions with Machine Learning Models for Improved Discharge Risk Assessment.
2022
·
Katherine Shi
, Vy Ho
, et al.
·
PubMed
·
13
An optimized reporter of the transcription factor hypoxia-inducible factor 1α reveals complex HIF-1α activation dynamics in single cells
2023
·
Stevan Jeknić
, Takamasa Kudo
, et al.
·
Journal of Biological Chemistry
·
9
PDF
Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma
2016
·
Qunfeng Wu
, Marda Jorgensen
, et al.
·
Gastroenterology Research and Practice
·
8
PDF
Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations
2023
·
Toriana R. Dabkowski
, Mallika Varkhedi
, et al.
·
JCO Precision Oncology
·
7
Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma
2023
·
Dorottya B. Kacsoh
, Michael J. Diaz
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
7
PDF
Utility of Specimens Positive for Neisseria gonorrhoeae by the Aptima Combo 2 Assay for Assessment of Strain Diversity and Antibiotic Resistance
2013
·
Kanti Pabbaraju
, Sallene Wong
, et al.
·
Journal of Clinical Microbiology
·
7
PDF
Chemical Complementarity of Blood-Sourced, Breast Cancer-Related TCR CDR3s and the CMV UL29 and IE1 Antigens is Associated with Worse Overall Survival
2024
·
Pooja Neerumalla
, Rahul Jain
, et al.
·
Biochemical Genetics
·
6
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma
2024
·
Tabitha R. Hudock
, Joanna J. Song
, et al.
·
Viral Immunology
·
6
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti‐EBV TCR CDR3s: Potential Relevance to Diffuse Large B‐Cell Lymphoma
2025
·
Nandini Goel
, Madeline C. Baker
, et al.
·
American Journal of Reproductive Immunology
·
4
TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease‐free survival
2023
·
Joanna J. Song
, Andrea Chobrutskiy
, et al.
·
Journal of Medical Virology
·
4
Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression
2023
·
Miguel A. Arias
, Konrad J. Cios
, et al.
·
Biology
·
4
PDF
TCR CDR3-CMV Antigen Chemical Complementaries Are Associated With a Worse Outcome for Renal Cell Carcinoma
2024
·
LILA ALKASSAB
, MICHAEL J. DIAZ
, et al.
·
Anticancer Research
·
3
PDF
Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs
2024
·
KASEY L. RIGBY
, MICHAEL J. DIAZ
, et al.
·
Cancer Genomics & Proteomics
·
2
PDF
Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma
2023
·
Joanna J. Song
, Andrea Chobrutskiy
, et al.
·
Viral Immunology
·
2
TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma
2023
·
Tabitha R. Hudock
, Vayda R. Barker
, et al.
·
Cancer Biomarkers
·
2
PDF
Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancer
2025
·
Madeline C. Baker
, Nandini Goel
, et al.
·
Cancer Causes & Control
·
1
Survival Distinctions for Cases Representing Immunologically Cold Tumors via Intrinsic Disorder Assessments for Blood-Sourced TRB Variable Regions
2024
·
Arpan Sahoo
, Etienne C. Gozlan
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor Timelapse
2024
·
Taha I. Huda
, Diep Nguyen
, et al.
·
Clinical Colorectal Cancer
·
1
Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma
2024
·
Michael J. Diaz
, Jessica Quach
, et al.
·
Melanoma Research
·
1
The differential usage of molecular machinery in brain cancer patients with iron-enriched glioma environments
2022
·
Lucke-Wold Brandon
, Diaz Michael Joseph
, et al.
·
Journal of Surgery and Surgical Research
·
1
Isolated Cervical Seminoma Without Testicular or Mediastinal Primary: A Rare Extragonadal Germ Cell Tumor Presentation
2026
·
Nikita Jhangiani
, Saivaroon Gajagowni
, et al.
·
Case Reports in Oncological Medicine
PDF
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq files
2025
·
Madeline C. Baker
, Srijit Paul
, et al.
·
Human Immunology
A high range of intrinsic disorder values for tumor resident, T-cell receptor beta V-complementarity determining region 3-J amino acid sequence assemblies correlates with better melanoma outcomes
2025
·
Joyce J. Zhu
, Arpan Sahoo
, et al.
·
Melanoma Research
Abstract A008: Better outcomes for ovarian cancer associated with the detection of anti-EBV TCR CDR3s: Potential relevance to diffuse large B-cell lymphoma
2024
·
Nandini Goel
, Madeline C Baker
, et al.
·
Cancer Immunology Research
Show more works
View as search
Works count:
29
Citation count:
264
H-index:
7
I10-index:
2
Year
Topic
Type